Post Categories
Boosting Oncology Research with Artificial Intelligence
May 6, 2024
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing the precision of cancer diagnostics and accelerating drug development processes. AI and machine…
The Future of Oncology Treatment
May 1, 2024
The future of oncology holds immense promise, thanks to the tireless efforts of medical researchers. From innovative oncology drugs like antibody-drug conjugates to advancements…
Oncology Drug Development: The Current State of Affairs
April 29, 2024
Death rates for cancer are lower than ever, having declined as much as 33 percent since 1991. This is largely thanks to innovations in…
Hacking the Nervous System to Improve Cancer Treatment
April 22, 2024
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the…
Oncology Drug Development: A Short History
April 17, 2024
Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel. The history of oncology…
New Class of Weight Loss Drugs Shows Promise in Treating Heart Disease
April 15, 2024
NodThera, a biotech company based in Cambridge, England, is developing a new class of medicines that inhibit the NOD-, LRR- and pyrin domain-containing protein…
COVID-19 Wiped Out a Flu Strain, Spurring Revamped Vaccine Strategy
April 8, 2024
Annual flu shots in the United States are going to be made a little differently this year, as one of the flu strains usually…
Scientists Harness Brain Waves for Life-Changing Neuroprosthetics
April 3, 2024
Genetic abnormalities, neurodegenerative conditions, and trauma can all impact speech, making it difficult or impossible for those affected to communicate verbally. And while resources…
Vivani Shifts to Weight Management with an Exenatide Implant
April 1, 2024
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani…
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
March 20, 2024
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
March 18, 2024
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
Navigating Changes to EU Clinical Trial Management: What You Need to Know
March 13, 2024
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials…
Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
October 14, 2024
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability…
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
